Annexon 2026 shareholder meeting vote results

Annexon, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 11, 2026.

Rhea-AI Filing Summary

Annexon, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 11, 2026. Stockholders elected Bettina M. Cockroft, M.D. with 101,594,745 votes for and 22,807,949 withheld, and Douglas Love, Esq. with 107,491,451 votes for and 16,911,243 withheld, with 17,818,815 broker non-votes for each.

Stockholders also approved additional proposals with strong support, including one receiving 142,016,122 votes for, 185,546 against and 19,841 abstentions, and another with 122,347,513 votes for, 1,986,387 against, 68,794 abstentions and 17,818,815 broker non-votes. A further proposal drew 129,051,256 votes for, 4,374,799 against and 8,795,454 abstentions.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Votes for Bettina M. Cockroft, M.D.: 101,594,745 votes Votes for Douglas Love, Esq.: 107,491,451 votes Broker non-votes for director items: 17,818,815 votes +3 more

6 metrics

Votes for Bettina M. Cockroft, M.D. 101,594,745 votes Director election at 2026 Annual Meeting

Votes for Douglas Love, Esq. 107,491,451 votes Director election at 2026 Annual Meeting

Broker non-votes for director items 17,818,815 votes Per director nominee at 2026 Annual Meeting

Proposal vote with highest support 142,016,122 for / 185,546 against Unspecified proposal at 2026 Annual Meeting

Second proposal key tally 122,347,513 for / 1,986,387 against Unspecified proposal with broker non-votes

Third proposal key tally 129,051,256 for / 4,374,799 against Unspecified proposal without broker non-votes

Key Terms

Annual Meeting of Stockholders, broker non-votes, emerging growth company, Common Stock, par value $0.001 per share

4 terms

Annual Meeting of Stockholders financial

"Annexon, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders"

broker non-votes financial

"the number of broker non-votes with respect to each matter"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

emerging growth company regulatory

"Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Common Stock, par value $0.001 per share financial

"Common Stock, par value $0.001 per share | | ANNX"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Annexon (ANNX) report from its 2026 Annual Meeting?

Annexon reported finalized voting results from its 2026 Annual Meeting of Stockholders. Shareholders elected two directors and approved several proposals with large majorities, indicating broad support for the board’s recommended items based on the disclosed vote tallies.

Which directors were elected at Annexon (ANNX)’s 2026 Annual Meeting?

Shareholders elected Bettina M. Cockroft, M.D. and Douglas Love, Esq. as directors. Cockroft received 101,594,745 votes for and 22,807,949 withheld, while Love received 107,491,451 votes for and 16,911,243 withheld, plus 17,818,815 broker non-votes for each.

How strong was shareholder support for Annexon (ANNX)’s proposals in 2026?

Support was high across the reported proposals. One item received 142,016,122 votes for versus 185,546 against, with 19,841 abstentions, while another drew 122,347,513 for and 1,986,387 against, alongside 68,794 abstentions and 17,818,815 broker non-votes.

Did Annexon (ANNX) report broker non-votes in its 2026 meeting results?

Yes. For the director elections, Annexon reported 17,818,815 broker non-votes for each nominee. One additional proposal also showed 17,818,815 broker non-votes, indicating some items were treated as non-routine by intermediaries for voting-discretion purposes.

What was the outcome of the final proposal reported by Annexon (ANNX)?

The final reported proposal received 129,051,256 votes for, 4,374,799 against, and 8,795,454 abstentions, with no broker non-votes listed. The large margin between for and against votes indicates the proposal passed comfortably based on the disclosed figures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:16 PM EDT Learn about SEC filing dates

false 0001528115 0001528115 2026-06-11 2026-06-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 11, 2026

ANNEXON, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39402		27-5414423
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1400 Sierra Point Parkway, Bldg C, Suite 200

Brisbane, California 94005

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (650) 822-5500

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		ANNX		The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

Annexon, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on June 11, 2026. The following is a brief description of each matter voted upon at the Annual Meeting and the number of votes cast for, withheld or against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable.

1. The election of two nominees to serve as Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders or until such earlier time as their respective successors are duly elected and qualified. The following two Class III directors were elected by the votes indicated.

		For				Withheld				Broker Non-Votes
Bettina M. Cockroft, M.D.			101,594,745				22,807,949				17,818,815
Douglas Love, Esq.			107,491,451				16,911,243				17,818,815

2. The ratification of the selection by the Audit Committee of our Board of Directors of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The selection was ratified by the votes indicated.

For		Against		Abstain		Broker Non-Votes
142,016,122		185,546		19,841		—

3. The approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers.

For		Against		Abstain		Broker Non-Votes
122,347,513		1,986,387		68,794		17,818,815

4. The approval of an amendment to the Company’s amended and restated certificate of incorporation to increase the number of authorized shares of common stock from 300,000,000 to 500,000,000.

For		Against		Abstain		Broker Non-Votes
129,051,256		4,374,799		8,795,454		—

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 12, 2026						Annexon, Inc.
				By:		/s/ Jennifer Lew
						Jennifer Lew
						Executive Vice President and Chief Financial Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.1 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 18.3 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 11.4 KB